FDA Forgoes Sponsor Support In Safety Study Of Contrast Agents To Avoid Potential Bias
This article was originally published in The Pink Sheet Daily
Executive Summary
Instead of requiring sponsors to conduct a study, the agency is providing grant to the University of Pittsburgh Medical Center to create a prospective registry that will examine the relationship between exposure to gadolinium-based contrast agents and nephrogenic systemic fibrosis.